A detailed history of Alexander Randolph Advisory, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Alexander Randolph Advisory, Inc. holds 348,727 shares of VTRS stock, worth $4.61 Million. This represents 3.58% of its overall portfolio holdings.

Number of Shares
348,727
Previous 347,587 0.33%
Holding current value
$4.61 Million
Previous $3.69 Billion 9.58%
% of portfolio
3.58%
Previous 3.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$10.32 - $12.13 $11,764 - $13,828
1,140 Added 0.33%
348,727 $4.05 Billion
Q2 2024

Aug 07, 2024

SELL
$10.05 - $12.02 $39,677 - $47,454
-3,948 Reduced 1.12%
347,587 $3.69 Billion
Q1 2024

May 06, 2024

BUY
$11.27 - $13.53 $5,015 - $6,020
445 Added 0.13%
351,535 $4.2 Billion
Q4 2023

Feb 02, 2024

BUY
$8.77 - $10.85 $3.08 Million - $3.81 Million
351,090 New
351,090 $3.8 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Alexander Randolph Advisory, Inc. Portfolio

Follow Alexander Randolph Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alexander Randolph Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alexander Randolph Advisory, Inc. with notifications on news.